Lynne B Klasko-Foster1,2,3, Katie B Biello1,3,4,5, William Lodge1,3, Jennifer Olson1, Matthew J Mimiaga1,4,5,6,7,8. 1. Center for Health Promotion and Health Equity, Brown University School of Public Health, Providence, Rhode Island, USA. 2. Department of Psychiatry and Human Behavior, Warren Alpert Medical School, Brown University, Providence, Rhode Island, USA. 3. Department of Behavioral and Social Health Sciences and Brown University School of Public Health, Providence, Rhode Island, USA. 4. Department of Epidemiology, Brown University School of Public Health, Providence, Rhode Island, USA. 5. The Fenway Institute, Fenway Health, Boston, Massachusetts, USA. 6. Department of Epidemiology, UCLA Fielding School of Public Health, Los Angeles, California, USA. 7. Department of Psychiatry and Biobehavioral Sciences, UCLA Geffen School of Medicine, Los Angeles, California, USA. 8. UCLA Center for LGBTQ Advocacy, Research and Health, Los Angeles, California, USA.
Abstract
Introduction: Coronavirus disease 2019 (COVID-19) has impacted researchers' ability to continue to deliver HIV prevention and treatment interventions face to face. Although telehealth has been an important strategy to maintain research operations during the current pandemic, participants at increased risk of or living with HIV are often at higher risk of also experiencing poverty, housing instability, and other challenges that may present obstacles to successful remote delivery. Methods: We provide descriptions of remote adaptations to two randomized controlled efficacy trials of behavioral interventions for primary and secondary HIV prevention with descriptive enrollment and retention data. Results and Conclusions: Best practices for implementing telemedicine and e-health procedures are discussed, including procedures for addressing remote participation barriers (economic, health literacy, etc.) and other challenges, such as building rapport and staff support (NCT03092531 and NCT03175159).
Introduction: Coronavirus disease 2019 (COVID-19) has impacted researchers' ability to continue to deliver HIV prevention and treatment interventions face to face. Although telehealth has been an important strategy to maintain research operations during the current pandemic, participants at increased risk of or living with HIV are often at higher risk of also experiencing poverty, housing instability, and other challenges that may present obstacles to successful remote delivery. Methods: We provide descriptions of remote adaptations to two randomized controlled efficacy trials of behavioral interventions for primary and secondary HIV prevention with descriptive enrollment and retention data. Results and Conclusions: Best practices for implementing telemedicine and e-health procedures are discussed, including procedures for addressing remote participation barriers (economic, health literacy, etc.) and other challenges, such as building rapport and staff support (NCT03092531 and NCT03175159).
Entities:
Keywords:
ART adherence; HIV prevention; efficacy trial; remote intervention; telemedicine
Authors: Oliver N Refugio; Mabel M Kimble; Cara L Silva; James E Lykens; Christian Bannister; Jeffrey D Klausner Journal: J Acquir Immune Defic Syndr Date: 2019-01-01 Impact factor: 3.731
Authors: Randolph D Hubach; Andrew M O'Neil; Mollie Stowe; Justin Hamrick; Zachary Giano; Joseph M Currin Journal: AIDS Patient Care STDS Date: 2020-11 Impact factor: 5.078
Authors: Hemen N Saifu; Steven M Asch; Matthew Bidwell Goetz; Jason P Smith; Christopher J Graber; Dennis Schaberg; Benjamin C Sun Journal: Am J Manag Care Date: 2012-04 Impact factor: 2.229
Authors: Amanda Moreland; Christine Herlihy; Michael A Tynan; Gregory Sunshine; Russell F McCord; Charity Hilton; Jason Poovey; Angela K Werner; Christopher D Jones; Erika B Fulmer; Adi V Gundlapalli; Heather Strosnider; Aaron Potvien; Macarena C García; Sally Honeycutt; Grant Baldwin Journal: MMWR Morb Mortal Wkly Rep Date: 2020-09-04 Impact factor: 17.586
Authors: Jaclyn M W Hughto; Lisa Peterson; Nicholas S Perry; Alex Donoyan; Matthew J Mimiaga; Kimberly M Nelson; David W Pantalone Journal: J Subst Abuse Treat Date: 2020-10-09
Authors: Matthew J Mimiaga; David W Pantalone; Katie B Biello; Tiffany Rose Glynn; Christopher M Santostefano; Jennifer Olson; Dana J Pardee; Jaclyn M W Hughto; Josibel Garcia Valles; Adam W Carrico; Kenneth H Mayer; Steven A Safren Journal: BMC Public Health Date: 2018-07-25 Impact factor: 3.295
Authors: Matthew J Mimiaga; Lisa M Kuhns; Katie B Biello; Jennifer Olson; Sam Hoehnle; Christopher M Santostefano; Jaclyn M W Hughto; Hadeis Safi; Peter Salhaney; Diane Chen; Robert Garofalo Journal: BMC Public Health Date: 2018-07-13 Impact factor: 3.295
Authors: Anna Junkins; Christina Psaros; Corilyn Ott; Andres Azuero; Crystal Chapman Lambert; Karen Cropsey; Robert Savage; Jessica E Haberer; Steven A Safren; Mirjam-Colette Kempf Journal: J Health Psychol Date: 2020-06-09